{"id":"NCT05338086","sponsor":"mAbxience Research S.L.","briefTitle":"A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis.","officialTitle":"A Randomised, Double-blind, Parallel, Multinational Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of MB09 (Proposed Denosumab Biosimilar) vs. Prolia® (EU-sourced) in Postmenopausal Osteoporosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-03-16","primaryCompletion":"2023-12-14","completion":"2024-05-22","firstPosted":"2022-04-20","resultsPosted":"2025-03-21","lastUpdate":"2025-03-21"},"enrollment":558,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Postmenopausal Women With Osteoporosis"],"interventions":[{"type":"DRUG","name":"MB09 (denosumab biosimilar)","otherNames":[]},{"type":"DRUG","name":"EU-Prolia","otherNames":[]},{"type":"DIETARY_SUPPLEMENT","name":"Elemental Calcium","otherNames":[]},{"type":"DIETARY_SUPPLEMENT","name":"Vitamin D","otherNames":[]}],"arms":[{"label":"MB09-MB09","type":"EXPERIMENTAL"},{"label":"Prolia-MB09","type":"ACTIVE_COMPARATOR"},{"label":"Prolia-Prolia","type":"ACTIVE_COMPARATOR"}],"summary":"This was a randomized, double-blind, parallel, multicenter, multinational study to compare the efficacy, pharmacokinetics, pharmacodynamics, safety and immunogenicity of MB09 versus Prolia® in postmenopausal women with osteoporosis","primaryOutcome":{"measure":"Efficacy: Percentage Change From Baseline (%CfB) in Lumbar Spine Bone Mineral Density (LS-BMD) at 52 Weeks - Modified Full Analysis Set (mFAS)","timeFrame":"Baseline (Screening), up to Week 52","effectByArm":[{"arm":"MB09","deltaMin":5.86,"sd":0.26},{"arm":"EU-Prolia","deltaMin":5.66,"sd":0.25}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"55 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":10},"locations":{"siteCount":64,"countries":["Bulgaria","Estonia","Georgia","Hungary","Latvia","Mexico","Poland","Serbia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":19,"n":277},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","COVID-19","Arthralgia","Urinary tract infection"]}}